Cramer’s lightning round: I prefer Moderna stock over Novavax – CNBC

Novavax: “I have to tell you even after today’s run in Moderna, I still prefer Moderna’s stock than Novavax because I think that Moderna can do a lot more with its formulation than Novavax ever can.”… [+1264 chars]

View The Article On: CNBC

Powered By

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

To Top